118 HRES 1165 IH: Expressing support for the designation of April as “Co-Occurring Disorders Awareness Month”. U.S. House of Representatives 2024-04-20 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

IV118th CONGRESS2d SessionH. RES. 1165IN THE HOUSE OF REPRESENTATIVESApril 20, 2024Mr. LaLota submitted the following resolution; which was referred to the Committee on Energy and CommerceRESOLUTIONExpressing support for the designation of April as Co-Occurring Disorders Awareness Month.

Whereas a co-occurring disorder, also known as dual diagnosis, is the condition of having a mental illness and a comorbid substance use disorder; Whereas, according to the Substance Abuse and Mental Health Services Administration’s 2022 National Survey on Drug Use and Health, approximately 21,500,000 adults in the United States have a co-occurring disorder; Whereas people with mental illness are more likely to experience a substance use disorder than those not affected by a mental illness; Whereas no specific combinations of mental and substance use disorders are defined uniquely as co-occurring disorders; Whereas the presence of two or more disorders can complicate diagnosis and treatment; Whereas integrating both screening and treatment for mental and substance use disorders leads to a better quality of care and health outcomes for those living with co-occurring disorders by treating the whole person; Whereas increased awareness leads to earlier detection; and Whereas early detection and integrated treatment can together improve outcomes and quality of life for people with co-occurring disorders: Now, therefore, be it

That the House of Representatives— (1)expresses support for the designation of Co-Occurring Disorders Awareness Month; and (2)recognizes the importance of— (A)improving awareness; (B)advancing research; and (C)developing new treatments and diagnostics for co-occurring disorders.